Catherine Demers

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi request reprint ACE inhibitors in heart failure: what more do we need to know?
    Catherine Demers
    Department of Medicine, Division of Cardiology, McMaster University, Hamilton, Ontario, Canada
    Am J Cardiovasc Drugs 5:351-9. 2005
  2. ncbi request reprint Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure
    Catherine Demers
    McMaster University, Hamilton, Ontario, Canada
    JAMA 294:1794-8. 2005
  3. ncbi request reprint The role of angiotensin II receptor blockers in the treatment of heart failure patients
    Michael Theal
    Hamilton Health Sciences Corporation General Division, McMaster University, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada
    Congest Heart Fail 9:29-34. 2003
  4. doi request reprint Screening for cognitive deficits using the Montreal cognitive assessment tool in outpatients ≥65 years of age with heart failure
    Karen Harkness
    Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    Am J Cardiol 107:1203-7. 2011
  5. ncbi request reprint Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure
    Andrew T Yan
    Heart and Stroke Richard Lewar Centre of Excellence, Toronto, Ontario, Canada
    J Card Fail 12:514-9. 2006
  6. ncbi request reprint Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis
    Rosa Roccaforte
    Population Health Research Institute, McMaster University, and Hamilton Health Sciences, Ontario, Canada
    Eur J Heart Fail 7:1133-44. 2005
  7. ncbi request reprint Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials
    Philip Jong
    Heart and Stroke Richard Lewar Centre of Excellence, Division of Cardiology, University Health Network, University of Toronto, Toronto, Canada
    J Am Coll Cardiol 39:463-70. 2002
  8. ncbi request reprint Growth hormone therapy in heart failure: where are we now?
    Catherine Demers
    Hamilton Health Sciences HHS, HHS General Division, Hamilton, Ontario, L8L 2X2 Canada
    Congest Heart Fail 9:84-90. 2003
  9. ncbi request reprint Living and dying with heart failure in long-term care: experiences of residents and their family members
    Sharon Kaasalainen
    Associate Professor, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    Int J Palliat Nurs 19:375-82. 2013
  10. ncbi request reprint Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes
    Shamir R Mehta
    Department of Medicine, Mc Master University, Hamilton Health Sciences, Hamilton, ON, Canada
    Can J Physiol Pharmacol 83:98-103. 2005

Collaborators

Detail Information

Publications13

  1. ncbi request reprint ACE inhibitors in heart failure: what more do we need to know?
    Catherine Demers
    Department of Medicine, Division of Cardiology, McMaster University, Hamilton, Ontario, Canada
    Am J Cardiovasc Drugs 5:351-9. 2005
    ..Although the use of ACE inhibitors may be appealing in patients with HF and preserved LV systolic function, there is currently no evidence from large clinical trials to support this...
  2. ncbi request reprint Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure
    Catherine Demers
    McMaster University, Hamilton, Ontario, Canada
    JAMA 294:1794-8. 2005
    ..Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of myocardial infarction (MI), but it is not known whether angiotensin receptor blockers have the same effect...
  3. ncbi request reprint The role of angiotensin II receptor blockers in the treatment of heart failure patients
    Michael Theal
    Hamilton Health Sciences Corporation General Division, McMaster University, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada
    Congest Heart Fail 9:29-34. 2003
    ..The results from further studies are awaited to clarify the role of ARBs in the treatment of heart failure...
  4. doi request reprint Screening for cognitive deficits using the Montreal cognitive assessment tool in outpatients ≥65 years of age with heart failure
    Karen Harkness
    Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    Am J Cardiol 107:1203-7. 2011
    ..Future studies need to determine if the MoCA can identify the presence of CI that is predictive of adverse clinical outcomes in the HF population...
  5. ncbi request reprint Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure
    Andrew T Yan
    Heart and Stroke Richard Lewar Centre of Excellence, Toronto, Ontario, Canada
    J Card Fail 12:514-9. 2006
    ..We hypothesized that increased plasma MMP levels correlate with increased left ventricular (LV) volumes and reduced LV ejection fraction (LVEF) in patients with HF...
  6. ncbi request reprint Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis
    Rosa Roccaforte
    Population Health Research Institute, McMaster University, and Hamilton Health Sciences, Ontario, Canada
    Eur J Heart Fail 7:1133-44. 2005
    ..Disease management programmes (DMP) have been advocated to improve long term outcomes of heart failure (HF) patients...
  7. ncbi request reprint Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials
    Philip Jong
    Heart and Stroke Richard Lewar Centre of Excellence, Division of Cardiology, University Health Network, University of Toronto, Toronto, Canada
    J Am Coll Cardiol 39:463-70. 2002
    ..We sought to determine the effect of angiotensin receptor blockers (ARBs) on mortality and hospitalization in patients with heart failure (HF)...
  8. ncbi request reprint Growth hormone therapy in heart failure: where are we now?
    Catherine Demers
    Hamilton Health Sciences HHS, HHS General Division, Hamilton, Ontario, L8L 2X2 Canada
    Congest Heart Fail 9:84-90. 2003
    ..Despite the lack of benefit demonstrated in small, short-term, randomized clinical trials, further studies are needed to assess the potential role of this adjuvant therapy in heart failure patients...
  9. ncbi request reprint Living and dying with heart failure in long-term care: experiences of residents and their family members
    Sharon Kaasalainen
    Associate Professor, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    Int J Palliat Nurs 19:375-82. 2013
    ..The findings from this study contribute to our understanding of residents' and family members' experiences in managing residents' HF in LTC. ..
  10. ncbi request reprint Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes
    Shamir R Mehta
    Department of Medicine, Mc Master University, Hamilton Health Sciences, Hamilton, ON, Canada
    Can J Physiol Pharmacol 83:98-103. 2005
    ..Despite this worse prognosis, patients with ACS developing CHF are less likely to be referred for invasive management...
  11. pmc Heart failure and cognitive impairment: challenges and opportunities
    George A Heckman
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Clin Interv Aging 2:209-18. 2007
    ..Preliminary evidence suggests that optimal HF therapy in elderly patients may preserve or even improve cognitive function, though the impact on related outcomes remains to be determined...
  12. doi request reprint Shared electronic vascular risk decision support in primary care: Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III) randomized trial
    Anne Holbrook
    Division of Clinical Pharmacology and Therapeutics, 105 Main Street E, Hamilton, Ontario, Canada
    Arch Intern Med 171:1736-44. 2011
    ..However, very few high-quality studies are set in routine, community-based clinical care, and no consistent evidence of an effect on patient outcomes has been found...
  13. ncbi request reprint Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?
    Catherine Demers
    HHS General Division, Hamilton Ontario
    Expert Opin Investig Drugs 14:1009-18. 2005
    ..The randomised studies showing benefit consistently used growth hormone every other day. Further studies are needed to assess the potential role of this adjuvant therapy in patients with heart failure...